The lack of SSTR2 imaging or immunohistochemical analysis of SSTR2 expression before and after relacorilant treatment is another limitation for patient cases 3 and 4; however, SSTR2 imaging is not part of the standard diagnostic evaluation of ACTH-secreting pituitary tumors (44). Here, SSTR2 is linked to pituitary tumor.